Opko Health Inc
Research Opko Health Inc (OPK) on Bullrun: market cap USD 1.11B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOPK
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 1.11B
- Financial periodQ2 2026
- RevenueUSD 163.58M
- Net income-USD 8.42M
- Free cash flow-USD 46.50M
- Gross margin48.9%
Valuation Snapshot
latest market cap is USD 1.11B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 606.88M | -USD 225.68B | -USD 190.82M | 33.9% | -0.3 | USD 364.41M | USD 4.00M | USD 1.27B |
| FY2024 | USD 713.14M | -USD 53.22B | -USD 208.50M | 30.6% | -0.08 | USD 426.58M | USD 440.21M | USD 1.37B |
| FY2023 | USD 863.50M | -USD 188.86B | -USD 44.47M | 36.8% | -0.25 | USD 95.88M | USD 9.72M | USD 1.39B |
| FY2022 | USD 1.00B | -USD 328.41B | -USD 119.77M | 28.7% | -0.46 | USD 153.19M | USD 11.01M | USD 1.56B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.11B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 956.43M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 987.18M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.17B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 965.86M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.28B | n/a | n/a | n/a |
About Opko Health Inc
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Opko Health Inc's market cap?
Opko Health Inc's market capitalization is USD 1.11B.
What does Opko Health Inc do?
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system.